Journal profile · GERIATRICS & GERONTOLOGY-CLINICAL NEUROLOGY
American Journal of Alzheimers Disease and Other Dementias
ISSN 1533-3175 · eISSN 1938-2731 · SAGE Publications Inc. · UNITED STATES · Bimonthly · Founded 2000
American Journal of Alzheimers Disease and Other Dementias: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.22; fully open access; APC about USD 2,650; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 22 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
American Journal of Alzheimers Disease and Other Dementias is published by SAGE Publications Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Geriatric Care and Nursing Homes and Alzheimer's disease research and treatments, together about 56.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
American Journal of Alzheimer's Disease and Other Dementias® (AJADD) accepts original papers from professionals and researchers on the frontlines of Alzheimer's care, dementia, and clinical depression, including those who deal with Alzheimer's patients every day. AJADD is a peer-reviewed, open access journal. In every issue, you will find down-to-earth clinical information on: The latest research on Alzheimer's disease from the molecular underpinnings of the disease to its associated behaviors.Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia.New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias. Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences.Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process.Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to American Journal of Alzheimer's Disease and Other Dementias® today!This journal is a member of the Committee on Publication Ethics (COPE).If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC), currently $3200 is payable*. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.*The APC is subject to taxes where applicable. Please see further details here.This journal changed its publication mode from subscription to open access in January 2020. Content from 1999-2019 is hosted free-access. Please see this page for information on reuse rights of archival material. Submit your manuscript today at https://mc.manuscriptcentral.com/AJAD.
From the journal's Aims & Scope
Research area (LetPub): GERIATRICS & GERONTOLOGY-CLINICAL NEUROLOGY
Editor-in-chief Raymond Chuen-Chung ChangPublisher website
Editorial board by country: 7 in mainland China (about 10%); most named United States 44, Mainland China 7, Hong Kong, China 3, Italy 2, Australia 2 (70 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine35.6%
- Geriatric Care and Nursing HomesHealth Professions11.3%
- Alzheimer's disease research and treatmentsMedicine9.3%
- Intergenerational Family Dynamics and CaregivingSocial Sciences5.1%
- Family Caregiving in Mental IllnessPsychology3.3%
- Palliative Care and End-of-Life IssuesMedicine3.1%
- Cholinesterase and Neurodegenerative DiseasesMedicine2%
- Mental Health and PsychiatryArts and Humanities2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Geriatrics & Gerontology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Geriatrics & Gerontology | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Geriatrics & Gerontology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.22LetPub ·
- Impact factor (publisher)
- 3.3Publisher website ·
- 5-year impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 1LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 52LetPub ·
- h-index
- 94OpenAlex ·
- i10-index
- 1,212OpenAlex ·
- 2-year mean citedness
- 2.5OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 23LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 2,592 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 7 |
| 2025 | 22 | 22 | 53 |
| 2024 | 26 | 26 | 120 |
| 2023 | 33 | 33 | 371 |
| 2022 | 35 | 35 | 577 |
| 2021 | 30 | 30 | 489 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 25.8%Publisher website ·
- Submission to first decision
- 7 daysPublisher website ·
- Acceptance to publication
- 16 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-SA, CC BY-ND, CC BY-NC, CC BY-NC-SA, CC BY-NC-ND | |
| OpenAlex | USD 2,650 | — | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Keywords
- ≥ 5
- Reference style
- AMA
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted15
- brief communicationView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- brief reportView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- case reportView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- commentaryView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- correspondenceView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- editorialView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- hypothesisView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- letterView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- letter to the editorView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- letters to the editorView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- original articleView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- original researchView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- research reportView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- reviewView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
- viewpointView our Special Collections currently accepting submissions. All articles will be considered for publication; however, preferential consideration will be given…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
American Journal of Alzheimer's Disease & Other Dementias® is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover th…
Source ↗Publisher website ·- Peer review Peer review policy
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2000
- ISSN
- 1533-3175
- Electronic ISSN
- 1938-2731
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about American Journal of Alzheimers Disease and Other Dementias
What CAS zone is American Journal of Alzheimers Disease and Other Dementias in?
In the 2025 upgraded edition of the CAS Journal Ranking, American Journal of Alzheimers Disease and Other Dementias is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Geriatrics & Gerontology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of American Journal of Alzheimers Disease and Other Dementias?
The latest impact factor listed by LetPub is 3.22; CiteScore 5.9, h-index 94.
How long does peer review take at American Journal of Alzheimers Disease and Other Dementias?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 25.8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of American Journal of Alzheimers Disease and Other Dementias?
According to the journal's author guidelines: Keywords: ≥ 5; Reference style: AMA; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of American Journal of Alzheimers Disease and Other Dementias based?
Of the 70 board members whose country the journal's board page names, 7 (about 10%) are in mainland China; the countries named most often are United States (44), Mainland China (7) and Hong Kong, China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index American Journal of Alzheimers Disease and Other Dementias?
According to LetPub and DOAJ records, American Journal of Alzheimers Disease and Other Dementias is indexed in SCIE, Scopus and DOAJ.
Is American Journal of Alzheimers Disease and Other Dementias open access, and what is the APC?
American Journal of Alzheimers Disease and Other Dementias is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .